GlassScriptPhysician profile
Sha'Ray Shaw
NPI 1104387430
$5,289.04
in general payments reported to CMS, 2019-2025
43 companies · $2,243 in 2025
The $2,243 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.61 · 2023: $542 · 2024: $2,434 · 2025: $2,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,932 · Education: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,931.99 |
| Education | $286.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $876.80 | 2023-2025 | Botox, Ubrelvy |
| Emd Serono, INC. | $818.32 | 2023-2025 | Mavenclad |
| Ucb, INC. | $390.02 | 2023-2025 | Briviact, Rystiggo, Fintepla |
| Novartis Pharmaceuticals Corporation | $303.82 | 2025 | |
| Acadia Pharmaceuticals INC | $254.45 | 2023-2025 | Nuplazid, Daybue |
| Genentech USA, INC. | $244.76 | 2023-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Eisai INC. | $236.68 | 2024-2025 | |
| Pfizer INC. | $212.13 | 2023-2025 | |
| Biogen, INC. | $194.87 | 2023-2025 | Vumerity, Tysabri, Skyclarys |
| Lundbeck LLC | $191.21 | 2023-2025 | Vyepti, Rexulti |
| Amgen INC. | $127.70 | 2021-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $127.49 | 2023-2024 | Ultomiris, Soliris |
| Livanova USA, INC. | $111.92 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Lilly USA, LLC | $106.82 | 2023-2025 | Amyvid, Kisunla |
| Tg Therapeutics, INC. | $94.03 | 2024-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sha'Ray Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.